As occurs for loss of Trp53 in the Eμ-Myc background, we observed accelerated tumour onset in the mice reconstituted with Eμ-Myc/dCas9a-SAMKI/+/sgMdm2 HSPCs compared to control mice. The gene discussed is MYC; the disease is neoplasm.